The Ultimate Directory on Healthcare Webinars

Sexually transmitted infections (STIs) are particularly concerned about AMR because of the widespread resistance to most medicines used to treat Neisseria gonorrhoeae in many parts of the world. Other STI pathogens with potential AMR include Mycoplasma genitalium and Trichomonas vaginalis. The department of Global HIV, Hepatitis and STIs Programmes at WHO will participate in the global annual awareness campaign to raise global awareness and understanding on AMR, an important example of One Health collaboration. This year, the departments of AMR and HIV/STIs will organize a joint webinar to launch and discuss 2 WHO Technical products, that are under the Enhanced Gonococcal AMR Surveillance Programme (EGASP) umbrella. It will also be a great opportunity to bring experts, country experience, surveillance data, diagnostics and therapeutics interventions in the pipeline together in one webinar.

This live webinar will be a forum to discuss how we can move forward in ensuring pharmaceutical companies manufacture responsibly to limit the risk of AMR. The live webinar builds on examples from a new report published by the Access to Medicine Foundation in August 2023 that sets out the clear steps pharmaceutical companies can take to limit AMR risk by manufacturing responsibly. The webinar will touch upon the major changes needed to improve the landscape, as well as the roles that different stakeholders have to play, including companies, regulators, procurers and investors.

You are invited to join us for an Analyst Teach-In to explore the potential of gammaCore™ non-invasive vagus nerve stimulation (nVNS). This exclusive event, tailored for analysts and industry experts, aims to provide a comprehensive understanding of the mechanism of action and the diverse range of potential applications of non-invasive vagus nerve stimulation.

Discover an informative webinar delving into commercial manufacturing in messenger RNA (mRNA) clinical therapies, new capacity installations and unique partnering models in commercial manufacturing. mRNA and cell/gene therapies represent cutting-edge approaches in the realm of biomedicine, with a focus on innovative disease targeting and treatment. These fields are rapidly evolving, characterized by intricate landscapes, and share common challenges that demand inventive solutions for their development, scaling and eventual commercialization.In this webinar, the featured speaker will discuss new capacity installations and unique partnering models and provide key updates on their progress toward commercial manufacturing of plasmid DNA (pDNA), mRNA, lipid nanoparticle (LNP) and fill/finish.

This webinar will focus on giving survivors a voice in the awareness and advocacy for antimicrobial resistance. Join us to hear inspiring stories and learn how we can work together to combat this global health threat.

The latest advancements in prophy cups, hand instruments, and handpieces help elevate the standard of care in dental hygiene. This webinar offers a comprehensive exploration of these essential tools, focusing on their evolution, new market innovations, and benefits. The benefits include superior biofilm removal, enhanced infection control, and better ergonomics. Leveraging these technologies effectively in daily practice helps with the biggest goal of all: improving patient care.

Learn why controlling your blood sugar is important, how this class can help, and have the opportunity to ask questions.

Discover a groundbreaking webinar delving into multifaceted strategies aimed at enhancing diversity within the realm of Alzheimer’s disease (AD) research. Addressing significant challenges rooted in the widespread lack of trust within diverse patient populations, the featured speakers forge collaborative efforts with advocacy groups, who serve as crucial bridges between the healthcare system and the communities they serve. Going beyond conventional screening practices, these strategies also involve extensive examination of medical records and employ a diverse array of tactics to identify potential patients who might otherwise go unnoticed. Innovation plays a pivotal role in not only tracking and reporting progress but also in educating these underrepresented patient populations. This webinar involves the open exchange of ideas, acknowledging that the path to solutions is neither instantaneous nor linear. Ultimately, this comprehensive approach encapsulates the principles of diversity, equity and inclusion (DE&I), serving as a model for advancing equitable access to Alzheimer’s research.

The development of effective vaccines is among the greatest advancements in public health to combat infectious diseases. It is a complex multi-year and multi-stakeholder process that requires well-designed strategy, partnership, and preparedness among the clinical, operational, and laboratory experts. In this webinar, hear from experts on the importance of having an integrated approach among the clinical and laboratory teams well before the protocol development and how robust laboratory and IT capabilities along with innovative automation help improve the efficiency of vaccine development.

Discover an informative webinar exploring the impact of osmolality in bioprocessing and in correlation with immunoglobulin G (IgG) production. Osmolality is described as the measurement of the contribution of all the dissolved solutes to the osmotic pressure of a solution. In biopharma, osmolality is usually used as a critical quality control check for cell culture media, buffers, and formulated drug products. It is also used as a critical process parameter during upstream cell culture and downstream filtration.The Cell Technology group at the National Institute for Bioprocessing Research and Training (NIBRT) focuses on the development of bioprocesses using mammalian cells to produce recombinant proteins, monoclonal antibodies, and viral vaccines. There is also a particular interest in the bioprocess conditions that can be used to control the biochemical structure and the post-translational modifications of glycoproteins and hence the quality of biopharmaceuticals.Osmolality is routinely used in the Cell Technology group as a QC tool, similar to the routine application in the biopharma industry. However, osmolality is applied as an experimental measurement to correlate with IgG production, nutrient depletion studies, and bioprocessing applications.In this webinar, the featured speaker will describe the impact of osmolality assessment in correlation with IgG production when examining the effect of plant protein hydrolysates as additives, in a media development project. When examining the effect of changing media composition to affect IgG glycosylation, osmolality was tracked and correlated with growth and productivity.In the investigation into the recoverability of cells at various stages of nutrient depletion, osmolality measurements were utilized to correlate the suitability of culture conditions in 're-fed' media, vs. controls of complete media. These preliminary investigations are in the process of being scaled up to the bioreactor level (bench scale) where osmolality validation will be used on samples taken in at-line process analytical technology (PAT) instrumentation development.Join this webinar to gain insights into osmolality in correlation with IgG production in a media development project.